Abstract
 
2000
 
ARTEMETHER-LUMEFANTRINE FOR THE TREATMENT OF MULTIDRUG-RESISTANT FALCIPARUM MALARIA.
 
van Vugt M, Looareesuwan S, Wilairatana P, McGready R, Villegas L, Gathmann I, Mull R, Brockman A, White NJ, Nosten F.
 
Shoklo Malaria Research Unit, Mae Sod, Thailand.
 
The efficacy and safety of the 6-dose regimen of artemether-lumefantrine were bassessed in an open randomized trial in children and adults presenting with acute, uncomplicated Plasmodium falciparum malaria in Thailand between November 1997 and March 1998. 200 patients were enrolled in 2 centres: 150 received artemether-lumefantrine (i.e., a median total dose of 9.6 mg/kg [interquartile range 8.7-10.7] and 57.9 mg/kg of lumefantrine [52.4-64.0]) and 50 the standard combination of artesunate (12 mg/kg over 3 d) and mefloquine (25 mg/kg). All patients had rapid initial clinical and parasitological responses. The 28 d cure rates were high: 97.7% (95% confidence interval [95% CI] 93.5-99.5%) for artemether-lumefantrine and 100% (95% CI 92.5-100%) for artesunate-mefloquine. The 6-dose regimen of artemether-lumefantrine was better tolerated than, and as effective as, artesunate-mefloquine, the current standard treatment in this area of multidrug-resistant P. falciparum malaria.
 
Published in: Trans R Soc Trop Med Hyg. 2000 Sep-Oct;94(5):545-8.
 
Last updated: March 24, 2008
 
 
   
Copyright © 2008 Faculty of Tropical Medicine, Mahidol University. All rights reserved.
Webmaster : tmwww@mahidol.ac.th